UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 1 filers reported holding CIDARA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,913,0002,9270.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,937,044$2,460,0002.09%
Stonepine Capital Management, LLC 2,311,530$2,936,0001.35%
BVF INC/IL 6,861,127$8,714,0000.32%
5AM Venture Management, LLC 1,134,511$1,441,0000.27%
Nantahala Capital Management 5,270,458$6,693,0000.24%
Knott David M Jr 428,896$545,0000.18%
West Family Investments, Inc. 368,910$469,0000.13%
JEPPSON WEALTH MANAGEMENT, LLC 110,525$140,0000.07%
Castleview Partners, LLC 6,986$5,501,0000.04%
XTX Topco Ltd 39,446$50,0000.03%
View complete list of CIDARA THERAPEUTICS INC shareholders